Search for Clinical Trial Results

Sponsored By

Hepatomegaly - 5 Studies Found

Status Study
Completed Study Name: Lanreotide as Treatment of Polycystic Livers
Condition:
  • Polycystic Liver Disease
  • Hepatomegaly
  • Drug: Placebo
  • Drug: Lanreotide
Completed Study Name: Open-Label Extension of LOCKCYST Trial
Condition:
  • Polycystic Liver Disease
  • Hepatomegaly
  • Polycystic Kidney, Autosomal Dominant
  • Polycystic Liver Disease
  • Drug: Octreotide Participants

Active, not recruiting Study Name: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Condition:
  • Anemia
  • Chronic Lymphocytic Leukemia
  • Fatigue
  • Date: 2014-01-27
    Interventions:
    • Drug: Cyclophosphamide Given I
No longer available Study Name: Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
Condition: Gaucher Disease
Date: 2009-08-18
Interventions: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) Intravenous infusion every two weeks a